Controlled Release of Bi-Layered EGCG Tablets Using 3D Printing Techniques
Journal of Pharmaceutical Research International,
Epigallo-catechin Gallate (or EGCG) is a polyphenol which is withdrawn from green tea and is commercially available as Epigallocatechin gallate. Epigallo-catechin gallate is known to have been used as dye and food colorants, but it also has many medicinal properties like anti-inflammatory, anti-microbial, anti-diabetic, anti-obesity, and anti-cancer. Keeping these medical properties in mind, in the present research paper, a 3D printing technique evolving a desktop based 3D printer to extrude tablets along with the active drug ingredient and other excipients that are used as binders and disintegrants. The method adapted in the formulation of a3D printed tablet in this research makes the tablet suitable for immediate and sustained release and does not affects it’s certain physical and mechanical properties such as hardness, friability, and weight variation. The tablets which are extruded from the 3D printer are the bi-layer tablets with controlled release. With the involvement of the 3D printer, the cost of printing the bi-layered tablets have found to be very low which makes the method cost efficient. The output bi-layer tablet has been developed using various analysis and specified standard apparatus and method so that the set standards of the tablet does not get affected. The immediate release and the sustained release methods were studied separately. The final stage of the research completes when the 3D printed tablets with set time intervals for the initial and sustained release and without changing the set mechanical properties of the tablet are obtained.
- Bi-layer tablets
- 3D printer.
How to Cite
Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Resear- ch; 2006.
Higdon JV, Frei B. Tea Catechins and Polyphenols: Health Effects, Metabolism, and Antioxidant Functions. Critical Reviews in Food Science and Nutrition; 2003.
Shankar S, Ganapathy S, Hingorani SR, R K Srivastava. EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front. Biosci; 2008.
Singh BN, Shankar S, Srivastava RK. Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications. Biochem. Pharmacol. 2011:82(12)1807–1821.
PC Gaine et al. Are dietary bioactives ready for recommended intakes? Adv. Nutr; 2013.
Lupton D. The pedagogy of disgust: The ethical, moral and political implications of using disgust in public health campaigns. Critical Public Health; 2015.
Wallace TC, Blumberg JB, Johnson EJ, A Shao. Dietary bioactives: Establishing a scientific framework for recommended intakes. Adv. Nutr; 2015.
Alhnan MA, Okwuosa TC, Sadia M, Wan KW, Ahmed W, Arafat B. Emergence of 3D Printed Dosage Forms: Opportunities and Challenges. Pharmaceutical Research; 2016.
Rowe CW, Katstra WE, Palazzolo RD, Giritlioglu B, Teung P, Cima MJ. Multimechanism oral dosage forms fabricated by three dimensional printing(TM). J. Control. Release; 2000.
Chu C, Deng J, Man Y, Qu Y. Green tea extracts epigallocatechin-3-gallate for different treatments. Biomed Res. Int. 2017;5615647.
Katiyar SK, Elmets CA, Agarwal R, Mukhtar H. Protection against ultraviolet‐b radiation‐induced local and systemic suppression of contact hypersensitivity and edema responses in c3h/hen mice by green tea polyphenols. Photochem. Photobiol; 1995.
Nguyen TTH et al. Biological characterization of epigallocatechin gallate complex with different steviol glucosides. Biotechnol. Bioprocess Eng; 2017.
Dow, Using METHOCEL Cellulose Ethers for Controlled Release of Drugs in Hydrophilic Matrix Systems. Matrix; 2000.
Sastry SV, Nyshadham JR, Fix JA. Recent technological advances in oral drug delivery - A review. Pharmaceutical Science and Technology Today; 2000.
Jivraj M, Martini LG, Thomson CM. An overview of the different excipients useful for the direct compression of tablets. Pharmaceutical Science and Technology Today; 2000.
Rosca ID, Vergnaud JM. Evaluation of the characteristics of oral dosage forms with release controlled by erosion. Comput. Biol. Med; 2008.
Parmar J, Rane M. Tablet formulation design and manufacture: Oral immediate release application. Pharma Times; 2009.
GM pharmaceutical preformulation and formulation: A practical guide from candidate drug selection to commercial dosage form. New York; 2009.
Scoutaris N, Alexander MR, Gellert PR, Roberts CJ. Inkjet printing as a novel medicine formulation technique. J. Control. Release; 2011.
Sandler N, et al. Inkjet printing of drug substances and use of porous substrates-towards individualized dosing. J. Pharm. Sci.; 2011.
Katstra WE, Palazzolo RD, Rowe CW, Giritlioglu B, Teung P, Cima MJ. Oral dosage forms fabricated by Three Dimensional Printing (TM). J. Control. Release; 2000.
Abd-Allah FI, Dawaba HM, Ahmed AM. Preparation, characterization, and stability studies of piroxicam-loaded microemulsions in topical formulations. Drug Discov. Ther; 2010.
Blume RW, Davis RD, Keyser DJ, Guaifenesin sustained release formulation and tablets. US. 2002;6:252-372 .
Remington JP, Beringer P. Remington : The science and practice of pharmacy. Philadelphia: Lippincott Williams & Wilkins; 2006.
Bushra R, Shoaib MH, Aslam N, Hashmat D, Masud-Ur-Rehman. Formulation development and optimization of ibuprofen tablets by direct compression method. Pak. J. Pharm. Sci; 2008.
Folttmann H, Quadir A. Copovidone - A copolymer with unique formulation properties. Drug Deliv. Technol; 2008.
United States Pharmacopeial Convention, the United States Pharmacopeia : USP 24 : the National Formulary : NF 19, March 9-12, 1995 ; Rockville, Md. Rockville, Md.: United States Pharmacopeial Convention; 1999.
Nagadivya P, Ramakrishna R, Sridhar G, Bhanushashank R. Effect of various binding agents on tablet hardness and release rate profiles of diclofenac sodium tablets. Int. J. Res. Pharm. Sci; 2012.
Patra CN, Kumar AB, Pandit HK, Singh SP, Devi MV. Design and evaluation of sustained release bilayer tablets of propranolol hydrochloride. Acta Pharm; 2007.
Bijank G, Rabindra D, Soumyadeep G, Manas C, Amitava B. Formulation development studies of bilayer tablet glipizide: A novel and evolutionary approach in the treatment of diabetes. Asian J. Pharm. Clin. Res; 2013.
Abstract View: 265 times
PDF Download: 162 times